RA
INSM icon

RiverPark Advisors’s Insmed INSM Stock Holding History

RiverPark Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Sell
431
-8
-2% -$969 0.02% 134
2026
Q1 		$71.8K Buy
439
+107
+32% +$16.5K 0.03% 124
2025
Q4 		$57.8K Buy
332
+71
+27% +$13K 0.02% 138
2025
Q3 		$37.6K Buy
+261
New +$32K 0.02% 130

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

RiverPark Advisors's INSM Position: Q2 2026 in Review

RiverPark Advisors reduced its Insmed (INSM) stake by 1.8% in Q2 2026, selling an estimated $969 and leaving 431 shares worth $46K. The position accounts for 0.02% of the portfolio, ranked #134.

RiverPark Advisors first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $71.8K in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • RiverPark Advisors held 431 shares of Insmed worth $46K as of Q2 2026.
  • RiverPark Advisors sold 8 Insmed shares in Q2 2026, an estimated $969.
  • Insmed made up 0.02% of RiverPark Advisors's portfolio in Q2 2026, its #134 holding.
  • RiverPark Advisors first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • RiverPark Advisors's Insmed position peaked at $71.8K in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on RiverPark Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.